Alba Luengo
Molecular Biology · 2016–2017
A researcher in the Science corpus: 2 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 88 citations into it
- Cancer Research — 79 citations into it
Whom Alba Luengo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Ralph J. Deberardinis
- M. V. Vander Heiden
- N. Hay
- Craig B. Thompson
- Peggy P. Hsu
- N. Pavlova
- I. Ben-Sahra
- J. Doherty
- Scott J. Dixon
- Navdeep S. Chandel
Papers from Alba Luengo's perspective
Ordered by how strongly the researchers Alba Luengo trusts endorse each paper. Same corpus, a different order for every researcher.
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (Nature)
- c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism (Nature)
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis (Proceedings of the National Academy of Sciences of the United States of America)
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation (Science)
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth (Nature)
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. (Journal of Clinical Investigation)
- The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzymatic activity that converts α-ketoglutarate to 2-hydroxyglutarate (Cancer Cell)
- ATP citrate lyase inhibition can suppress tumor cell growth. (Cancer Cell)
- Activation of a metabolic gene regulatory network downstream of mTOR complex 1. (Molecules and Cells)
- Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation (Cancer Cell)
Their papers
- Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer (2016) — 676 citations
- Targeting Metabolism for Cancer Therapy (2017) — 787 citations